h
hu
um
n
r
rh
hi
ov
vi
ir
ru
us
se
es
c
co
om
mi
ng
g
n
f
fr
ro
om
th
e
c
co
ol
ld
ab
bs
st
tr
ra
ac
ct
rhinoviru
infect
caus
least
virusrel
wheez
exacerb
cold
flulik
ill
infect
also
associ
otiti
media
sinus
pneumonia
annual
impact
human
rhinoviru
hrv
infect
cost
billion
healthcar
dollar
date
serotyp
hrv
classic
strain
divid
two
genet
distinct
speci
base
subgenom
sequenc
mani
appar
novel
strain
remain
uncharacter
circul
unknown
pattern
caus
undefin
ill
recent
genom
less
half
classic
strain
sequenc
april
remain
classic
hrv
genom
sequenc
report
data
inform
therapeut
develop
phylogenet
analysi
subset
hrv
strain
view
one
step
long
road
lead
comprehens
hrv
character
electron
version
articl
complet
one
found
onlin
r
rh
hi
ov
vi
ir
ru
us
se
es
mo
e
th
ha
n
ee
et
ts
th
e
e
ey
ye
e
human
infect
culturebas
method
hrv
detect
prevail
often
augment
strain
type
use
neutral
antisera
impract
insensit
method
result
misconcept
compar
influenza
viru
respiratori
syncyti
viru
exampl
hrv
straightforward
rel
minor
role
ill
think
limit
character
polymeras
chain
reaction
pcr
base
method
subsequ
start
reveal
extent
complex
hrvinduc
ill
identifi
frequent
occurr
codetect
includ
involv
hrv
strain
respiratori
specimen
associ
ill
singl
respiratori
viru
assum
viru
detect
requir
reexamin
confirm
associ
hold
true
previou
conceptdefin
hrvrelat
epidemiolog
conduct
without
knowledg
numer
cocircul
respiratori
virus
discov
sinc
bias
inabl
cultur
detect
certain
strain
speci
mani
centuri
conclus
hrv
need
revisit
use
modern
method
date
one
hrv
strain
hrvqpm
deliber
target
intens
studi
use
molecular
tool
larg
clade
diverg
interrel
strain
report
recogn
propos
third
speci
hrv
c
hrv
cs
found
entir
molecular
mean
specimen
collect
reflect
unsuit
cultur
sensit
comprehens
screen
hrv
cs
heavili
associ
wheez
ill
remain
uncultur
perhap
reflect
prefer
differ
cell
line
use
routin
n
ne
ew
w
g
ge
en
om
e
se
eq
qu
ue
en
nc
ce
es
r
ra
ai
se
e
ny
q
qu
ue
es
st
ti
io
ns
th
ey
ns
sw
er
r
turn
centuri
seen
mani
signific
advanc
understand
genet
divers
genom
featur
clinic
impact
infect
hrv
group
well
immunolog
interact
strain
first
classic
strain
offici
name
last
sequenc
untransl
region
complet
classic
strain
complet
set
region
avail
kistler
et
al
ad
genom
tapparel
et
al
includ
one
common
studi
data
provid
tool
expand
knowledg
phylogeni
evolut
epidemiolog
hrv
predict
drug
suscept
report
indic
subgenom
region
use
repres
known
genom
complet
sequenc
classic
strain
allow
comprehens
silico
analys
possibl
date
examin
entir
set
hrv
code
noncod
region
palmenberg
et
al
produc
data
support
recent
report
recombin
among
hrv
intens
analys
indic
drive
forc
behind
hrv
evolut
discrep
may
due
differ
number
classic
strain
sequenc
use
studi
differ
origin
virus
use
sequenc
way
predict
algorithm
configur
abil
hrv
recombin
practic
await
empir
evid
fascinatingli
one
ten
field
strain
sequenc
palmenberg
et
al
predict
involv
recombin
event
seven
classic
strain
aros
compar
one
event
american
type
cultur
collect
atcc
variant
strain
previous
one
strain
need
vari
epitop
consid
distinct
anoth
compar
molecular
rather
antigen
differ
two
variant
hrv
strain
found
differ
across
genom
almost
nucleotid
ident
equat
amino
acid
chang
result
amino
acid
ident
rais
sever
question
quickli
intrastrain
genet
variat
occur
variat
accumul
suffici
quantiti
requir
clinic
hrv
isol
pcr
detect
reconsid
distinct
strain
new
hrv
strain
activ
emerg
question
especi
import
given
obviou
impact
nucleotid
sequenc
variat
evolutionari
conclus
futur
studi
may
address
extent
locat
genet
differ
clonal
yet
lowpassag
field
strain
versu
cultureadapt
atcc
strain
palmenberg
et
al
also
propos
previous
identifi
hrv
small
diverg
clade
within
hrv
speci
renam
clade
may
repres
new
speci
hrv
align
togeth
two
three
member
clade
differ
nucleotid
ident
ten
amino
acid
ident
recogn
singl
strain
note
intern
committe
taxonomi
virus
ictv
set
amino
acid
ident
two
key
region
part
demarc
speci
within
genu
enteroviru
definit
met
genom
region
assign
clade
novel
speci
exhibit
averag
amino
acid
ident
clade
two
distinct
member
ident
hrv
strain
howev
clade
remain
similar
enough
hrv
strain
region
averag
ident
choic
receptor
major
group
similar
gc
content
clade
antivir
profil
similar
hrv
b
strain
antivir
group
genet
find
report
palmenberg
et
al
build
upon
describ
previous
classic
hrv
new
sequenc
data
valuabl
contribut
pure
knowledg
futur
ration
drug
design
address
outstand
phylogenybas
issu
howev
data
directli
contribut
clinic
relev
area
research
diagnost
assay
design
epidemiolog
immunolog
viral
interfer
coinfect
clinic
impact
differenti
diagnosi
infect
control
address
area
daunt
task
inform
futur
respiratori
viru
studi
whether
hrv
virus
undertak
allinclus
approach
toward
viru
character
give
statist
power
find
larg
popul
screen
regularli
regardless
symptom
address
persist
pathogen
virus
address
coinfect
interfer
across
multipl
year
address
recurr
season
casecontrol
condit
ideal
hospit
communitybas
set
would
f
fi
ig
gu
ur
e
scope
uncharacter
divers
within
hrv
supergroup
classic
novel
hrv
red
b
blue
c
green
speci
sequenc
align
use
muscl
within
geneiou
pro
circular
neighborjoin
tree
tamuranei
model
bootstrap
consensu
support
shown
node
space
permit
produc
use
geneiou
tree
builder
root
use
pink
sequenc
includ
report
palmenberg
et
al
label
multipl
strain
identifi
use
first
two
charact
genbank
access
code
atcc
identifi
origin
per
refer
put
novel
strain
variant
repres
termin
gray
circl
subgenom
fragment
span
nucleotid
junction
cva
coxsackieviru
hev
human
enteroviru
pv
polioviru
mani
novel
hrv
b
c
strain
found
hrvposit
respiratori
specimen
type
use
subgenom
region
figur
like
mani
sampl
extend
greater
period
time
sinc
hrv
strain
alway
recur
everi
year
singl
locat
like
current
pcrbase
method
could
identifi
novel
hrv
strain
rais
question
drive
develop
mani
strain
compar
small
number
strain
rna
viru
speci
mani
similar
strain
appar
retain
stabl
viral
entiti
time
palmenberg
et
al
conclud
futur
hrv
epidemiolog
make
use
full
genom
sequenc
rather
serotyp
clearli
serotyp
longer
best
even
frequent
practic
hope
futur
studi
determin
sequenc
region
suitabl
replic
subdivis
avoid
costli
timeconsum
technic
demand
complet
genom
sequenc
current
impract
diagnost
mani
clinic
research
laboratori
routin
sequenc
full
genom
everi
hrv
detect
task
made
especi
daunt
high
preval
virus
region
best
subgenom
target
enterotyp
previous
proven
suitabl
rhinotyp
howev
extent
intraspeci
recombin
render
subgenom
region
unreli
indic
strain
ident
new
sourc
uncertainti
genom
featur
support
treatment
strain
clade
speci
discret
viral
entiti
deserv
target
antivir
intervent
virolog
clinic
epidemiolog
character
rhinovirus
known
decad
often
consid
less
public
health
research
prioriti
virus
may
last
face
modern
molecular
epidemiolog
clinic
research
onslaught
due
intrigu
group
pathogen
ab
bb
br
ev
vi
ia
ti
io
ns
au
ut
th
ho
rs
c
co
nt
tr
ri
ib
bu
ut
ti
io
ns
author
contribut
write
manuscript
approv
final
version
au
ut
th
ho
rs
nf
fo
rm
ti
io
n
imm
lead
research
team
includ
kea
focus
identif
novel
respiratori
virus
follow
character
virolog
immunobiolog
featur
epidemiolog
clinic
impact
among
pediatr
popul
ac
ck
kn
ow
wl
le
ed
dg
gm
en
nt
ts
